ScholarIQanswers from OpenAlex & ORCID
Puyuan Xing
ResearcherPublications, citations & collaboration network
Puyuan Xing is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Puyuan Xing have?
ScholarIQindexed works
Puyuan Xing has 279 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Puyuan Xing have?
ScholarIQcitation count
Puyuan Xing has 3,005 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Puyuan Xing?
ScholarIQh-index
Puyuan Xing has an h-index of 29 in OpenAlex.
What is the i10-index of Puyuan Xing?
ScholarIQi10-index
Puyuan Xing has an i10-index of 77 in OpenAlex.
What is the ORCID of Puyuan Xing?
ScholarIQorcid
The ORCID for Puyuan Xing is on the source record.
What is the OpenAlex record for Puyuan Xing?
ScholarIQopenalex
The OpenAlex for Puyuan Xing is on the source record.
What are the most-cited papers on Puyuan Xing?
ScholarIQmost cited works
Phase I Study and Biomarker Analysis of Pyrotinib, a Novel Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
Fei Ma, Qiao Li, Shanshan Chen, Wenjie Zhu, Ying Fan, Jiayu Wang, Yang Luo, Puyuan Xing, Bo Lan, Meiying Li, Zongbi Yi, Ruigang Cai, Peng Yuan, Pin Zhang, Qing Li, Binghe Xu
Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis
Puyuan Xing, Fan Zhang, Guoqiang Wang, Yu Xu, Chengcheng Li, Shouzheng Wang, Yiying Guo, Shangli Cai, Yan Wang, Junling Li
Clinical characteristics and medical service utilization of lung cancer in China, 2005–2014: Overall design and results from a multicenter retrospective epidemiologic survey
Jufang Shi, Le Wang, Ning Wu, Junling Li, Zhouguang Hui, Shangmei Liu, Boyan Yang, Shugeng Gao, Jiansong Ren, Huiyao Huang, Juan Zhu, Chengcheng Liu, Jin‐Hu Fan, Shi-Jun Zhao, Puyuan Xing, Ye Zhang, Ning Li, Wendong Lei, Debin Wang, Yunchao Huang, Xianzhen Liao, Xiaojing Xing, Lingbin Du, Li Yang, Yuqin Liu, Yongzhen Zhang, Kai Zhang, You‐Lin Qiao, Jie He, Min Dai
Current management of chemotherapy-induced neutropenia in adults: key points and new challenges
Yi Ba, Yuankai Shi, Wenqi Jiang, Jifeng Feng, Ying Cheng, Li Xiao, Qingyuan Zhang, Wensheng Qiu, Binghe Xu, Rui‐Hua Xu, Bo Shen, Zhiguo Luo, Xiaodong Xie, Jianhua Chang, Mengzhao Wang, Yufu Li, Yue-Rong Shuang, Zuoxing Niu, Бо Лю, Jun Zhang, Li Zhang, Herui Yao, Conghua Xie, Huiqiang Huang, Wangjun Liao, Gongyan Chen, Xiaotian Zhang, Han‐Xiang An, Yanhong Deng, Ping Gong, Jianping Xiong, Qinghua Yao, Xin An, Cheng Chen, Yanxia Shi, Jialei Wang, Xiaohua Wang, Zhi‐Qiang Wang, Puyuan Xing, Sheng Yang, Chenfei Zhou
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial
Qiao Li, Xiuwen Guan, Shanshan Chen, Zongbi Yi, Bo Lan, Puyuan Xing, Ying Fan, Jiayu Wang, Yang Luo, Peng Yuan, Ruigang Cai, Pin Zhang, Qing Li, Dafang Zhong, Yifan Zhang, Jianjun Zou, Xiaoyu Zhu, Fei Ma, Binghe Xu